1. HBW Insight

Most U.S. Sunscreens Not So Hot, Reflecting FDA Failures – EWG

 
• By Lisa Gillespie

The majority of sunscreen products in the U.S. still don’t meet the Environmental Working Group’s standards. Just 25% of the sunscreen products evaluated for the group’s 2013 Sunscreen Guide pass muster, underscoring the need for a finalized sunscreen monograph and ingredient options for sunscreen formulators on par with those in Europe, EWG says.

FDA needs to improve its standards for sunscreens, which allow hazardous products to remain on the market, the Environmental Working Group says.

For the seventh edition of its annual Sunscreen Guide, EWG evaluated more than 1,400 sunscreens, moisturizers, lip and makeup products...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from HBW Insight

People In US Consumer Health News: Bayer North America Treasurer Takes On CFO Role, Too

 
• By Malcolm Spicer

Bayer North America CFO with firm since 2008; Cosette VP for quality, regulatory affairs; FDA labeling review official joins ProPharma; Lifecykel, UFC veterans launch Mongolian training camp; and Beverly Hills surgeons offer skin care supplement.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By David Ridley

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

Remote Regulatory Assessments Become Swiss Army Knife For US FDA’s Oversight Of Facilities

 
• By Malcolm Spicer

“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.